| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.8M | +21.4% |
| Cost of Revenue | $12.4M | +40.2% |
| Gross Profit | $97.3M | +19.4% |
| R&D Expense | $67.1M | +17.4% |
| SG&A Expense | $155.1M | +28.0% |
| Operating Income | -$124.9M | -29.0% |
| Pre-tax Income | -$153.4M | -23.7% |
| Income Tax | $78K | -97.2% |
| Net Income | -$153.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.7M | -35.6% |
| Short-term Investments | $49.3M | -55.4% |
| Accounts Receivable | $33.1M | +62.9% |
| Inventory | $16.5M | +78.4% |
| Current Assets | $186.0M | -32.6% |
| Total Assets | $200.5M | -29.8% |
| Current Liabilities | $46.4M | +1.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$162.4M | -67.9% |
| Capital Expenditures | $289K | -2.0% |
| Investing Cash Flow | $61.6M | +398.6% |
| Financing Cash Flow | $39.9M | -79.5% |
| Free Cash Flow | -$162.7M | -67.7% |
| -21.0% |
| EPS (Basic) | -$3.19 | -7.8% |
| Long-term Debt |
| $125.0M |
| +2.7% |
| Total Liabilities | $305.9M | +3.9% |
| Stockholders' Equity | -$105.5M | -1098.2% |